Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/28625
Title: Quantity and quality of airway clearance in children and young people with cystic fibrosis
Authors: Raywood, E
Shannon, H
Filipow, N
Tanriver, G
Stanojevic, S
Kapoor, K
Douglas, H
O'Connor, R
Murray, N
Black, B
Main, E
Keywords: airway clearance techniques;chest physiotherapy;paediatric;physiotherapy;respiratory
Issue Date: 7-Oct-2022
Publisher: Elsevier
Citation: Raywood, E. et al. (2023) 'Quantity and quality of airway clearance in children and young people with cystic fibrosis', Journal of Cystic Fibrosis, 22 (2), pp. 344 - 351. doi: 10.1016/j.jcf.2022.09.008.
Abstract: Children and young people with CF (CYPwCF) get advice about using positive expiratory pressure (PEP) or oscillating PEP (OPEP) devices to clear sticky mucus from their lungs. However, little is known about the quantity (number of treatments, breaths, or sets) or quality (breath pressures and lengths) of these daily airway clearance techniques (ACTs) undertaken at home. This study used electronic pressure sensors to record real time breath-by-breath data from 145 CYPwCF (6–16y) during routine ACTs over 2 months. ACT quantity and quality were benchmarked against individual prescriptions and accepted recommendations for device use. In total 742,084 breaths from 9,081 treatments were recorded. Individual CYPwCF maintained consistent patterns of ACT quantity and quality over time. Overall, 60% of CYPwCF did at least half their prescribed treatments, while 27% did fewer than a quarter. About 77% of pre-teens did the right number of daily treatments compared with only 56% of teenagers. CYPwCF usually did the right number of breaths. ACT quality (recommended breath length and pressure) varied between participants and depended on device. Breath pressures, lengths and pressure-length relationships were significantly different between ACT devices. PEP devices encouraged longer breaths with lower pressures, while OPEP devices encouraged shorter breaths with higher pressures. More breaths per treatment were within advised ranges for both pressure and length using PEP (30–31%) than OPEP devices (1–3%). Objective measures of quantity and quality may help to optimise ACT device selection and support CYPwCF to do regular effective ACTs.
Description: Supplementary materials are online at: https://www.sciencedirect.com/science/article/pii/S1569199322006865#sec0016 .
URI: https://bura.brunel.ac.uk/handle/2438/28625
DOI: https://doi.org/10.1016/j.jcf.2022.09.008
ISSN: 1569-1993
Other Identifiers: ORCiD: Emma Raywood https://orcid.org/0000-0002-0993-5115
ORCiD: Harriet Shannon https://orcid.org/0000-0003-2190-7245
ORCiD: Gizem Tanriver https://orcid.org/0000-0002-0195-5672
ORCiD: Sanja Stanojevic https://orcid.org/0000-0001-7931-8051
ORCiD: Helen Douglas https://orcid.org/0000-0002-5184-6300
ORCiD: Eleanor Main https://orcid.org/0000-0002-9739-3167
Appears in Collections:Dept of Health Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © 2022 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society. This is an open access article under the CC BY-NC-ND license ( https://creativecommons.org/licenses/by-nc-nd/4.0/ )862.02 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons